A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
Conditions: Head and Neck Cancer; Cervical Cancer; Non-small Cell Carcinoma; Melanoma; Ovarian Cancer; Anogenital Cancers; HPV - Anogenital Human Papilloma Virus Infection; HPV-Related Cervical Carcinoma; HPV-Related Carcinoma; HPV-Related Squamous Cell Carcino ma; HPV-Related Malignancy; HPV-Related Adenocarcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HPV-Related Adenosquamous Carcinoma; HPV-Associated Vaginal Adenocarcinoma; HPV-Related Endocervical Adenocarcinoma; HPV-Related Anal Squamous Cell Carcinoma; HPV-Related Verrucous Carcinoma; HPV-Related Penile Squamous Cell Carcinoma; HPV-Related Vulvar Squamous Cell Carcinoma; HPV Positive Rectal Squamous Cell Carcinoma Interventions: Biological: TSC-204-A0201; Biological: TSC-204-C0702; Biological: TSC-200-A0201; Biological: TSC-204-A0201 + TSC-204-C0702; Biological: TSC-204-A0201 + TSC-200-A0201 Sponsor: TScan Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Melanoma | Oropharyngeal Cancer | Research | Skin Cancer | Squamous Cell Carcinoma | Study